Acupoint TENS vs Resistance Training for Iron Deficiency Anemia

Recruiting now · Phase 4

Conditions studied: Iron Deficiency Anemia

In brief

The current study is designed to compare between the effect of transcutaneous electrical acupoint stimulation and resistance exercises on hemoglobin level in women with iron deficiency anemia.The design of this study will be a randomized controlled trial (RCT) pretest post-test assessment.Sixty women diagnosed with iron deficiency anemia will be recruited in this study from Kafrelshiekh University Hospital, Kafrelshiekh Governorate, Egypt. Their ages will be ranged from 20 to 30 years old, and they will be randomly divided into three equal (n= 20) groups. Change in hemoglobin concentration (g/dL) after the intervention period and changes in RBC count, MCV, MCH, RDW, serum ferritin, fatigue level, and functional exercise capacity after treatment will be measured.

Key facts

Study ID

NCT07605676

Run by

Cairo University

People needed

60

Starts

2026-01-15

Expected to finish

2026-10-15

Last updated by the study team

2026-05-26

Who can join

Age: 20 and older, up to 30. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Sixty women diagnosed with iron deficiency anemia within ≤6 months.
• Their hemoglobin concentrations ranging from 8.0 to 10.9 g/dL that classified as moderate anemia in accordance with the World Health Organization (WHO) criteria.
• The iron deficiency anemia resulted from the heavy monthly bleeding of menstrual cycle as reported by the women.
• Their age will be ranged from 20 and 30 years old.
• Their BMI will be ranged from 18.5 to 24.9 kg/m².
• They will have the same level of functional capacity assessed by 6-minute walking test.
• They will be receiving the same medical treatment programme.

You may not qualify if…

• Other causes of anemia (e.g., hemolytic anemia, anemia of chronic disease, megaloblastic anemia, thalassemia, or sickle cell disease).
• Severe anemia (hemoglobin < 8.0 g/dL)
• History of chronic kidney disease, liver disease, or malignancy.
• Current pregnancy or lactation, due to altered iron metabolism and hemoglobin thresholds.
• Recent blood transfusion or iron therapy (oral or intravenous) within the past 3 months.
• Use of hematopoietic agents (e.g., erythropoietin).
• Acute infection or inflammatory conditions at the time of enrollment.
• Inability or unwillingness to provide informed consent or comply with study procedures.
• Previous participation in complementary treatments/research within the last six months.

Where it is running

• Kafrelsheikh University — Cairo, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.